Skip to main content
AJNR: American Journal of Neuroradiology logoLink to AJNR: American Journal of Neuroradiology
. 2011 May;32(5):955–961. doi: 10.3174/ajnr.A2396

Carotid Artery Wall Thickness and Leukoaraiosis: Preliminary Results Using Multidetector Row CT Angiography

L Saba a,, L Pascalis b, R Sanfilippo c, M Anzidei d, R Bura c, R Montisci c, G Mallarini a
PMCID: PMC7965560  PMID: 21349963

Abstract

BACKGROUND AND PURPOSE:

LA is a condition caused by chronic cerebral ischemia and it represents an independent risk for stroke. The purpose of this work was to determine whether CAWT studied by using MDCTA is correlated with LA and its severity.

MATERIALS AND METHODS:

Ninety-eight patients ≥60 years of age were retrospectively studied by using multidetector row CT. Supra-aortic vessel analysis and brain CT were performed in the same procedure. In each patient, CAWT was measured with an internal digital caliper, and the presence and severity of LA were assessed. Correlation coefficients by using Spearman statistics and ROC curves were calculated. A P value < .05 was considered statistically significant.

RESULTS:

Measurements of the distal common CAWT ranged from 0.5 to 1.53 mm. A correlation between LA and increased CAWT was observed (Pearson correlation, 0.33; P < .001). On the basis of a threshold of 0.9 mm, an important statistical association between increased CAWT and LA (P < .0001) was found. With the same threshold, ROC curve analysis indicated a sensitivity of 55% and a specificity of 75% for LA.

CONCLUSIONS:

The results of this study show a statistically significant correlation between increased CAWT and LA (and its severity).


The term “LA,” first used by Hachinski et al,1 indicates the presence of patchy areas of low attenuation in the periventricular white matter. This condition is a common feature of the aging brain and is frequently seen in patients with hypertension, gait abnormalities, depression, and dementia.26 Moreover, LA represents an independent risk factor that can be used to predict future stroke.79 This condition is probably caused by chronic cerebral ischemia, but its pathogenesis and clinical significance are incompletely understood.10 Several articles suggested an association between carotid atherosclerosis and LA.1113

Sonography is a widely used noninvasive technique for imaging the carotid arteries and investigating the atherosclerotic processes that may affect the carotid arteries.1416 One of the most commonly used parameters for evaluating carotid atherosclerosis by using US is the IMT, which represents the quantification of the intima-media layers of the carotid artery.17 IMT is correlated with systemic atherosclerosis and predicts the risk of recurrent strokes.1820

Recently published articles21,22 suggested that MDCTA can evaluate the thickness of the carotid artery wall, referred to by Saba et al21 as CAWT, and presented results indicating significant agreement between MDCTA and CD-US in the measurement of CAWT and IMT.22

The purpose of this work was to investigate whether CAWT studied by using MDCTA is correlated with LA and its severity.

Materials and Methods

Patient Population

We created a data base from retrospective case material from our institution and then searched the data base prospectively as a hypothesis-driven scientific study. Inclusion criteria were ≥60 years of age and previous MDCT imaging of the brain and carotid arteries performed at the same sitting, whereas exclusion criteria were other possible causes of white matter hypoattenuation, such as multiple sclerosis, vasculitis, acute disseminated encephalomyelitis, or connective tissue diseases.23

From August 2009 to March 2010, 98 patients (65 men, 33 women; mean age, 72 years; age range, 60–82 years) met the above-mentioned criteria in our university hospital and were selected for the study.

Each patient underwent MDCTA for suspected carotid artery pathology. The inclusion criteria for performing MDCTA in our institution have previously been published11,14,21,22 and are as follows: the presence of an US examination that showed a pathologic stenosis and/or a plaque alteration, or US being unable to provide sufficient information about the degree of stenosis and plaque type—for example, in the presence of large calcified plaques with acoustic shadowing, high carotid bifurcation, or a thick neck (edema, patients with obesity). With US, plaque alteration was considered as the presence of a heterogeneous plaque, an irregular surface, intraplaque hemorrhage, and/or ulceration in the plaque. Exclusion criteria for the MDCTA examination were a known allergy to iodinated contrast material or elevated renal function tests.

Demographic details, including age, sex, and risk factors (hypertension, diabetes, coronary artery disease, dyslipidemia, and tobacco use) were recorded.

This retrospective review evaluated existing clinical data and records. No additional procedures were performed. The review was conducted in accordance with the guidelines of the research committee of our institution.

Classification of Cerebrovascular Symptoms

Patients were classified as symptomatic or asymptomatic according to the neurologic assessment documented in the clinical chart review. A patient with a TIA or stroke was considered as “symptomatic.” TIA was regarded as an episode of neurologic dysfunction, such as hemiparesis, hemiparesthesia, dysarthria, dysphasia, or monocular blindness for <24 hours. If the episode of neurologic dysfunction exceeded 24 hours, it was classified as a stroke. The time window for inclusion in the symptomatic group was 6 months; when a patient underwent an MDCTA examination >6 months after the TIA/stroke event, he or she was excluded from the symptomatic group and included in the asymptomatic group. A patient who had no current history of symptoms or who had a remote (>6-month) history of symptoms at the time of examination was considered “asymptomatic.” In our institution, the carotid arteries of asymptomatic patients are studied if the patient has diabetes and is >50 years of age and if the patient has undergone a cardiac intervention for coronary artery disease, an aortic intervention, or lower leg artery surgery.

Cardiovascular Risk Factors

Cardiovascular risk factors and coexisting comorbidities and treatment known before stroke or TIA are systematically recorded in our institution as described previously.11,14,21,22 In this study, we considered the following parameters: CAD, high blood pressure, dyslipidemia, diabetes, and cigarette smoking status. Diabetes was indicated by an abnormal fasting plasma glucose level (>7.9 mmol/L) or the current use of insulin or an oral hypoglycemic agent. Cigarette smoking status was categorized as never or current (if the patient had stopped in the last 24 months, he or she was considered a current smoker). “Dyslipidemia” was defined as abnormal fasting plasma cholesterol (low-attenuation lipoprotein cholesterol) levels (fasting cholesterol >5.0 mmol/L) or the current use of lipid-lowering agents. CAD was diagnosed in the presence of the following: 1) visible luminal narrowing of coronary arteries documented by coronary angiography or MDCTA, 2) a previous history of myocardial infarction, or 3) previous coronary interventional/surgical procedures. “Essential hypertension” was defined as a systolic blood pressure of >140 mm Hg and/or a diastolic blood pressure of >90 mm Hg or the current use of blood pressure−lowering drugs.

MDCTA Technique

All patients underwent MDCTA of the supra-aortic vessels by using a 16-detector multidetector-row CT system (Brilliance; Philips Healthcare, Best, the Netherlands). A basal scan was obtained and was followed by the angiographic phase in which 80 mL of contrast medium (iomeprol, Iomeron 400; Bracco, Milan, Italy) was injected into a cubital vein, by using a power injector at a flow rate of 5 mL/s and an 18-ga intravenous catheter. A bolus-tracking technique was used to calculate the correct timing of the scan. Dynamic monitoring scanning began 6 seconds after the beginning of the intravenous injection of contrast material. The trigger threshold inside the region of interest was set at +80 HU above the baseline. The delay between the acquisition of each monitoring scan was 1 second. When the threshold was reached, the patient was instructed not to breathe, and after an interval of 4 seconds, the scan was started in the caudocranial direction. CT technical parameters included the following: matrix 512 × 512; FOV, 14–19 cm; mAs, 180–200; kV, 120–140; section thickness, 1 mm; increment, 0.5 mm. The window level was preset according to Saba and Mallarini.24,25 Angiographic acquisition included the carotid siphon. None of the patients included in the study had a medical history of cardiac output failure or any contraindications to iodinated contrast media.

MDCTA of the Brain

CT brain studies were performed with the same scanner used for carotid analyses (Philips Brilliance). Acquisitions were performed before and after injection of contrast material from the base of the skull to the vertex. CT technical parameters included the following: matrix, 512 × 512; FOV, 25 cm; mAs, 320–340; 120–140 kV; section thickness, 2 mm; increment, 1 mm.

Analysis of Carotid Artery and CAWT

The degree of stenosis of each carotid artery was measured by using the North American Symptomatic Carotid Endarterectomy Trial criteria.2628 The degree of stenosis was calculated by selecting a reformat plane perpendicular to the lumen centerline. Particular attention was paid to avoid the key calculation pitfalls of percentage stenosis: The first step was to recognize near-occlusion (in this case, attempts to calculate a percentage may be fallacious), which was identified by 2 criteria: 1) evidence of narrowed poststenotic ICA, and 2) a poststenotic ICA that was similar to or smaller than the ipsilateral external carotid artery. Second, we measured the diameter of the normal ICA wall beyond the bulb where the walls were parallel,2628 4–6 cm distal to the plaque. Each carotid stenosis received the following grades: I, normal; II (1%–39%), mildly stenosed; III (40%–69%), moderately stenosed; IV (70%–99%), severely stenosed; and V, occluded.

CAWT, as indicated by Saba et al,22 and Fanning et al23 was measured at its thickest point on the distal (far) wall of the common carotid artery, where there was no evidence of plaque,29 2 cm proximal to the bulb. This distance was necessary because if the wall is measured close to a plaque, it should be thicker. Three measurements were performed at the 6, 9, and 12 o'clock positions for each carotid artery (Fig 1). We measured CAWT between the leading edge of the opacified lumen vessel and the external visible limit of the artery wall, where it was surrounded by adjacent adipose tissue. The individual subject's mean common carotid CAWT values were then obtained by averaging the values obtained for each carotid artery.

Fig 1.

Fig 1.

Examples of LA. A, Grade 0. B, Grade 1. C, Grade 2. D, Grade 4.

To perform logistic regression analyses, we also analyzed the type of plaque. For the measurement of Hounsfield unit attenuation, a circular or elliptic region-of-interest cursor was used in the predominant plaque area; those areas showing contamination by contrast material or beam hardening were carefully avoided. We used the classification proposed by de Weert et al3032: “fatty” (soft) plaque was a plaque with an attenuation <60 HU; “mixed (intermediate) plaque” was a plaque with an attenuation between 60 and 129 HU; and “calcified plaque” was a plaque with a attenuation of >130 HU.

Analysis of Brain MDCT

MDCT images of the brain were analyzed by reviewers who were blinded to the patient's demographic details, and 2 experienced radiologists quantified the white matter scores and resolved any differences by consensus. In this study, the hemispheric white matter score and corresponding ipsilateral carotid characteristics—degree of stenosis and type of plaque—were considered as a single unit of analysis.11,23 Therefore 196 carotid-hemisphere units were analyzed.

For white matter assessment, we used a visual scale for the severity of white matter change based on the European Task Force on Age-Related White Matter Changes.33 We used a 4-point grading scale as follows: 0, no lesions; 1, focal lesions >5 mm; 2, early confluent lesions; and 3, diffuse involvement of an entire brain region. For all patients, the highest score for each hemisphere was used in the analysis (Fig 2).

Fig 2.

Fig 2.

MDCTA axial image of a 79-year-old man. A, The white arrow indicates the right common carotid artery. B, A 200% magnification is shown, and the 3 measurements at 6, 9, and 12 o‘ clock positions are visible.

Statistical Analysis

Continuous data were described as the mean value ± SD. The normality of data distribution was assessed by using the Kolmogorov-Smirnov test. Age was boxplotted against LA severity and CAWT. The correlation coefficient between CAWT and LA severity was calculated by using a Spearman correlation (ρ). Logistic regression analysis was also performed to examine the relationship between the dichotomous variable LA and independent variables such as CAWT, age, class of carotid artery stenosis, sex, tobacco use, hypertension, dyslipidemia, and diabetes mellitus. The Cohen κ test34 was applied to assess the interobserver agreement for white matter scores. A value of <0.20 implied poor agreement; 0.21–0.40, fair agreement; 0.41–0.60, moderate agreement; 0.61–0.80, substantial agreement; and 0.81–1.0, almost perfect agreement. The Bland-Altman analysis was performed to analyze the interobserver agreement in the CAWT quantification. R software (www.r-project.org) was used for these analyses. A P value < .05 was considered to indicate statistical significance.

Results

General Results

The clinical features of the study group are shown in Table 1. In our cohort, we detected 54 patients with ischemic symptoms (17 strokes, 28 transitory ischemic attacks, 9 cases of amaurosis fugax) and 44 without ischemic symptoms. Measurements of the CAWT ranged from 0.5 to 1.53 mm. The normality of CAWT distribution, assessed by using the Kolmogorov-Smirnov test, was rejected with a P value of .046; therefore, the mean and median cannot be considered. Given the lack of normality, we used the Spearman statistic to evaluate the correlation between parameters. A statistically significant correlation was observed between CAWT values and LA (Spearman correlation, 0.33; 95% CI, 0.19–0.45; P < .0001) and between CAWT values and LA severity (Spearman correlation, 0.21; 95% CI, 0.08–0.34; P < .0035). Moreover, a statistically significant correlation between increased age and LA (Spearman correlation, 0.23; 95% CI, 0.09–0.36; P value < .0012) and between increased age and LA severity (Spearman correlation, 0.42; 95% CI, 0.29–0.53; P < .0001) was also recorded. Figure 3A, -B shows, respectively, the boxplot of LA severity against CAWT and age.

Table 1:

Clinical characteristics of the study populationa

Characteristic Patients
PValue
With LA (n = 76) Without LA (n= 22)
Age (yr) 75.5 ± 5.9 72.2 ± 6.4 .0027b
Symptoms 45 (59) 9 (41) .1286
Sex (male) 53 (70) 12 (55) .1843
Coronary artery disease 40 (53) 8 (36) .1789
Tobacco use 36 (47) 9 (41) .5924
Hypertension 61 (80) 15 (77) .7592
Diabetes 27 (36) 2 (9) .0167b
Dyslipidemia 50 (65) 10 (45) .0847
a

Values in parentheses are percentages.

b

P < .05.

Fig 3.

Fig 3.

A, Box-and-whisker plot representing CAWT values according LA severity. B, Box-and-whisker plot representing age value according to LA severity.

Logistic Regression Analysis

Logistic regression was performed to explore the relationship between CAWT, degree of carotid stenosis, type of plaque, age of patients, and other risk factors such as sex, tobacco use, hypertension, dyslipidemia, and diabetes mellitus. The results are shown in Table 2. Data from our study showed a statistically significant association between LA and CAWT, between LA and patient age, and between LA and fatty plaques (P = .0087, .0103, and 0.0276, respectively).

Table 2:

Logistic regression analysis

Variable Coefficient SE PValue OR 95% CI
Age 0.0803 0.0313 .0103a 1.0836 1.0192–1.1521
CAD −0.6227 0.4307 .1482 0.5365 0.2307–1.2478
CAWT 0.0811 0.0309 .0087a 1.0845 1.0207–1.1523
Carotid stenosis 0.2914 0.2012 .1175 0.7472 0.5038–1.1084
Diabetes −0.4957 0.4635 .2848 0.6091 0.2456–1.5108
Dislipidemia 0.3981 0.424 .3478 1.4889 0.6486–3.4181
Tobacco 0.4354 0.423 .3033 1.5456 0.6746–3.5411
Hypertension 0.5701 0.5076 .2614 1.7684 0.6539–4.7824
Sex (male) 0.3845 0.4254 .3661 1.4689 0.6381–3.3812
Mixed plaque 0.2273 0.4683 .6274 1.2552 0.5013–3.1427
Fatty plaque 1.1997 0.5447 .0276a 3.3192 1.1411–9.6542
Calcified plaque 0.4186 0.4134 .3113 1.5199 0.6759–3.4175
Constant −8.1382
a

P < .05.

ROC Curve Analysis

We also analyzed the relationship between LA and CAWT by using ROC statistics. The ROC curve analysis is shown in Fig 4. Area under the ROC curve was 0.729 ± 0.039 (95% CI, 0.661–0.790; P = .0001). From this ROC, we obtained the sensitivity, specificity, and positive and negative predictive values of each measure; a summary of these values is given in Table 3. On the basis of a threshold of 0.9 mm, ROC curve analysis indicated a sensitivity of 63% and a specificity of 72% for LA.

Fig 4.

Fig 4.

ROC curve analysis.

Table 3:

ROC curve analysis for specific measurements of CAWT versus LA

Criterion Sensitivity 95% CI Specificity 95% CI +LR −LR
≥0.5 100.00 97.6–100.0 0.00 0.0–8.3 1.00
<0.5 98.03 94.3–99.6 4.65 0.7–15.8 1.03 0.42
<0.6 94.08 89.1–97.3 20.93 10.1–36.0 1.19 0.28
<0.7 85.53 78.9–90.7 46.51 31.2–62.3 1.60 0.31
<0.8 73.68 65.9–80.5 58.14 42.1–73.0 1.76 0.45
<0.9a 62.80a 54.3–70.2a 72.09a 56.3–84.7a 2.24a 0.52a
<1.0 49.34 41.1–57.6 79.07 64.0–89.9 2.36 0.64
<1.1 35.53 27.9–43.7 86.05 72.1–94.7 2.55 0.75
<1.2 22.37 16.0–29.8 93.02 80.9–98.5 3.21 0.83
<1.3 7.24 3.7–12.6 97.67 87.7–99.6 3.11 0.95
<1.4 6.58 3.2–11.8 100.00 91.7–100.0 0.93
<1.5 0.00 0.0–2.4 100.00 91.7–100.0 1.00
a

selected threshold.

Reproducibility Analysis

Interobserver agreement in measuring LA showed optimal results with κ and weighted κ values of 0.856 and 0.893, respectively. Good results were also obtained in the analysis of interobserver reproducibility for LA severity, with a κ value of 0.734 and a weighted κ value of 0.771. Interobserver agreement in the CAWT analysis, calculated by using Bland-Altman plots, was also good (Fig 5).

Fig 5.

Fig 5.

Bland-Altman plot analysis for the CAWT reproducibility between observers.

Discussion

Evidence indicates that LA may predispose individuals to stroke,35 but conflicting conclusions have been reported that may be due to the heterogeneous presence of risk factors for LA formation among patients.36 LA formation probably involves multiple etiologies, and ischemic causalities could be significant for some and insignificant for others. Currently, it is possible to find 2 main hypotheses in the literature regarding LA etiology: ischemic and nonischemic. According to the first theory, LA is caused by insufficient blood supply to the cerebral white matter due to the vascular pathology,11,3739 and recent articles40,41 demonstrated that vessel attenuation in the deep white matter was significantly lower in patients with LA compared with healthy subjects (P = .018). According to the nonischemic hypothesis, LA may be due to the dilation of the perivascular spaces that surround normal arterioles or to atrophic changes that include gliosis or the loss of the myelinated axons seen in the normal-aging brain.4,4245

Increased IMT reflects the severity of arterial damage brought about by classic vascular risk factors and has been suggested as a measure of atherosclerosis, while prospective studies have shown that an increased IMT is an important predictor of cerebrovascular and coronary complications.44,46 Recently Saba et al21,22 demonstrated that MDCTA can be used to measure the thickness of the CAWT, and the results obtained indicated significant agreement between MDCTA and CD-US in the measurement of CAWT and IMT (correlation coefficient, r = 0.9855; 95% CI, 0.9808–0.989; the Mann Whitney U test indicated a P value of .377).

The purpose of this work was to investigate whether CAWT measured by using MDCTA is associated with LA and its severity. In our highly selected group, we observed a statistically significant correlation between CAWT values and LA (Spearman correlation, 0.33) and between CAWT values and LA severity (Spearman correlation, 0.21). The logistic regression analysis confirmed the correlation by indicating that CAWT was an independent variable associated with LA. These data are concordant with the observation of Manolio et al,47 who reported a correlation between LA and IMT measured by US; they demonstrated a strong and consistent relationship between LA and increasing carotid IMT. These results were recently confirmed by Tanaka et al.48

The association between LA and increasing age is well documented,4,11,4951 and for this reason, we decided to include only those patients ≥60 years of age to reduce the effect of age; however, the inclusion of subjects only ≥60 years of age represents a bias in this study and may limit the degree to which our results can be generalized to the entire population. Our results confirmed a significant statistical association between increasing age, LA, and LA severity (P = .0012 and <. 0001, respectively). We studied patients whose clinical examinations, carotid CTA/brain CT, and blood sampling were performed according to the same protocols. We believe that our cohort is relatively uniform for a hospital-based series, though the size of the cohort was relatively small. On the basis of a comparison between our patients' characteristics and other studies, we observed a higher incidence of patients with LA (77.5% in our study versus 51.2% in Fanning et al23). This result can easily be explained by the higher mean age of the patients belonging to our study group (72 years).

On the basis of the logistic regression analysis, we found no association between classic cerebrovascular risk factors and LA risk. Previous studies described an association between LA and associated risk factors for cerebrovascular disease,5255 such as diabetes, dyslipidemia, hypertension, and tobacco use. However, the association between LA and cerebrovascular risk factors is still being debated; Murray et al56 found a significant Pearson correlation between LA and diabetes, hypertension, low-attenuation lipoprotein, and cholesterol, but these associations were not confirmed by other authors.57

An interesting result observed in our study was the association between the presence of the fatty plaque type and LA (P = 0.0276). It is well known that the composition of the atherosclerotic plaque may play a significant role in the origin of cerebrovascular events.58 Our results support a previous study by Saba et al,11 which found a trend in the association of the presence of fatty plaques and LA (P = .08). Moreover, these results are concordant with the study by Altaf et al,59 which demonstrated that LA is associated with features that indicate plaque instability, showing that plaque activity may contribute to the development of LA.

Interobserver agreement in measuring LA showed optimal results with κ and weighted κ values of .856 and .893, respectively. Good results were also obtained in the analysis of interobserver reproducibility for LA severity, with a κ value of 0.734 and a weighted κ value of 0.771. These results are similar to those of previous studies.11 Interobserver agreement in the CAWT analysis, calculated by using a Bland-Altman plot (Fig 5) was also good.

There were several limitations to this study. First, this was a retrospective study; in fact, our patients were chosen from a retrospectively created data base, and this process may have led to bias in the composition of the cohort. A prospective study would probably provide even more accurate results. Second, in our institution, carotid CTA is performed when there is evidence of pathology confirmed by US; therefore, a large number of patients with no evidence of pathology were excluded from the study. Third, we studied only a subset of the patient population who were older than 60 years of age, to reduce the age effect in the LA analysis, but this is a very different demographic group compared with the general population, which thus limits the generalization of our results.

Conclusions

The results of this study showed, in this highly selected patient group, a statistically significant correlation between increased CAWT and LA (and its severity), whereas the degree of stenosis and the classic cardiovascular risk factors had no effect. The data presented are preliminary, and the generalization of our results is significantly limited by the potential selection bias associated with the methodology of our study.

Abbreviations

CAD

coronary artery disease

CAWT

carotid artery wall thickness

CD-US

color Doppler ultra-sonography

CI

confidence interval

CTA

CT angiography

ICA

internal carotid artery

IMT

intima-media thickness

LA

leukoaraiosis

LR

likelihood ratio

MDCTA

multidetector-row CT angiography

OR

odds ratio

ROC

receiver operating characteristic analysis

SE

standard error

TIA

transient ischemic attack

US

ultra-sonography

References

  • 1. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21–23 [DOI] [PubMed] [Google Scholar]
  • 2. Ovbiagele B, Saver JL. Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis 2006;22:83–90 [DOI] [PubMed] [Google Scholar]
  • 3. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review. Stroke 1995;26:1293–301 [DOI] [PubMed] [Google Scholar]
  • 4. Ylikoski A, Erkinjuntti T, Raininko R, et al. White matter hyperintensities on MRI in the neurologically nondiseased elderly: analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995;26:1171–77 [DOI] [PubMed] [Google Scholar]
  • 5. Madureira S, Verdelho A, Moleiro C, et al. Neuropsychological predictors of dementia in a three-year follow-up period: data from the LADIS study. Dement Geriatr Cogn Disord 2010;29:325–34 [DOI] [PubMed] [Google Scholar]
  • 6. Teodorczuk A, Firbank MJ, Pantoni L, et al. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med 2010;40:603–10 [DOI] [PubMed] [Google Scholar]
  • 7. Henon H, Vroylandt P, Durieu I, et al. Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke 2003;34:2935–40 [DOI] [PubMed] [Google Scholar]
  • 8. Streifler JY, Eliasziw M, Benavente OR. Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke 2003;34:1913–16 [DOI] [PubMed] [Google Scholar]
  • 9. Auriel E, Bornstien NM, Berenyi E, et al. Clinical, radiological and pathological correlates of leukoaraiosis. Acta Neurol Scand 2011;123:41–47 [DOI] [PubMed] [Google Scholar]
  • 10. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652–59 [DOI] [PubMed] [Google Scholar]
  • 11. Saba L, Sanfilippo R, Pascalis L, et al. Carotid artery abnormalities and leukoaraiosis in elderly patients: evaluation with MDCT. AJR Am J Roentgenol 2009;192:W63–70 [DOI] [PubMed] [Google Scholar]
  • 12. de Leeuw FE, de Groot JC, Bots ML. Carotid atherosclerosis and cerebral white matter lesions in a population-based magnetic resonance imaging study. J Neurol 2000;247:291–96 [DOI] [PubMed] [Google Scholar]
  • 13. Waterston JA, Brown MM, Butler P, et al. Small deep cerebral infarcts associated with occlusive internal carotid artery disease: a hemodynamic phenomenon? Arch Neurol 1990;47:953–57 [DOI] [PubMed] [Google Scholar]
  • 14. Saba L, Sanfilippo R, Montisci R, et al. Correlation between US-PSV and MDCTA in the quantification of carotid artery stenosis. Eur J Radiol 2010;74:99–103 [DOI] [PubMed] [Google Scholar]
  • 15. Xiong L, Deng YB, Zhu Y, et al. Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology 2009;251:583–89 [DOI] [PubMed] [Google Scholar]
  • 16. Jaff MR, Goldmakher GV, Lev MH, et al. Imaging of the carotid arteries: the role of duplex ultrasonography, magnetic resonance arteriography, and computerized tomographic arteriography. Vasc Med 2008;13:281–92 [DOI] [PubMed] [Google Scholar]
  • 17. Ward RP, Lammertin G, Virnich DE, et al. Use of carotid intima-media thickness to identify patients with ischemic stroke and transient ischemic attack with low yield of cardiovascular sources of embolus on transesophageal echocardiography. Stroke 2008;39:2969–74 [DOI] [PubMed] [Google Scholar]
  • 18. Talelli P, Terzis G, Katsoulas G, et al. Recurrent stroke: the role of common carotid artery intima-media thickness. J Clin Neurosci 2007;14:1067–72 [DOI] [PubMed] [Google Scholar]
  • 19. Tsivgoulis G, Vemmos K, Papamichael C, et al. Common carotid artery intima-media thickness and the risk of stroke recurrence. Stroke 2006;37:1913–16 [DOI] [PubMed] [Google Scholar]
  • 20. Heeringa J, van der Kuip DA, Hofman A, et al. Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam Study. Arch Intern Med 2007;167:382–87 [DOI] [PubMed] [Google Scholar]
  • 21. Saba L, Sanfilippo R, Pascalis L, et al. Carotid artery wall thickness and ischemic symptoms: evaluation using multi-detector-row CT angiography. Eur Radiol 2008;18:1962–71 [DOI] [PubMed] [Google Scholar]
  • 22. Saba L, Sanfilippo R, Montisci R, et al. Carotid artery wall thickness: comparison between sonography and multi-detector row CT angiography. Neuroradiology 2010;52:75–82 [DOI] [PubMed] [Google Scholar]
  • 23. Fanning NF, Walters TD, Fox AJ, et al. Association between calcification of the cervical carotid artery bifurcation and white matter ischemia. AJNR Am J Neuroradiol 2006;27:378–83 [PMC free article] [PubMed] [Google Scholar]
  • 24. Saba L, Mallaring G. MDCTA of carotid plaque degree of stenosis: evaluation of interobserver agreement. AJR Am J Roentgenol 2008;190:W41–46 [DOI] [PubMed] [Google Scholar]
  • 25. Saba L, Mallarini G. Window settings for the study of calcified carotid plaques with multidetector CT angiography. AJNR Am J Neuroradiol 2009;30:1445–50 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Fox AJ. How to measure carotid stenosis. Radiology 1993;186:316–18 [DOI] [PubMed] [Google Scholar]
  • 27. Morgenstern LB, Fox AJ, Sharpe BL, et al. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery: North American Symptomatic Carotid Endarterectomy Trial (NASCET) group. Neurology 1997;48:911–15 [DOI] [PubMed] [Google Scholar]
  • 28. Fox AJ, Eliasziw M, Rothwell PM, et al. Identification, prognosis, and management of patients with carotid artery near occlusion. AJNR Am J Neuroradiol 2005;26:2086–94 [PMC free article] [PubMed] [Google Scholar]
  • 29. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study Stroke 1999;30:841–50 [DOI] [PubMed] [Google Scholar]
  • 30. de Weert TT, Ouhlous M, Meijering E, et al. In vivo characterization and quantification of atherosclerotic carotid plaque components with multidetector computed tomography and histopathological correlation. Arterioscler Thromb Vasc Biol 2006;26:2366–72 [DOI] [PubMed] [Google Scholar]
  • 31. de Weert TT, Ouhlous M, Zondervan PE, et al. In vitro characterization of atherosclerotic carotid plaque with multidetector computed tomography and histopathological correlation. Eur Radiol 2005;15:1906–14 [DOI] [PubMed] [Google Scholar]
  • 32. de Weert TT, de Monyé C, Meijering E, et al. Assessment of atherosclerotic carotid plaque volume with multidetector computed tomography angiography. Int J Cardiovasc Imaging 2008;24:751–59 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Wahlund LO, Barkhof F, Fazekas F, et al. European Task Force in Age-Related White Matter Changes: a new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318–22 [DOI] [PubMed] [Google Scholar]
  • 34. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74 [PubMed] [Google Scholar]
  • 35. Kuller LH, Longstreth WT, Arnold AM, et al. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004;35:1821–25 [DOI] [PubMed] [Google Scholar]
  • 36. Pantoni L, Simoni M, Pracucci G, et al. Visual rating scales for age-related white matter changes (leukoaraiosis): can the heterogeneity be reduced? Stroke 2002;33:2827–33 [DOI] [PubMed] [Google Scholar]
  • 37. Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002;13:7–10 [DOI] [PubMed] [Google Scholar]
  • 38. Brown WR, Moody DM, Thore CR, et al. Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis Ann N Y Acad Sci 2000;903:39–45 [DOI] [PubMed] [Google Scholar]
  • 39. Moody DM, Brown WR, Challa VR, et al. Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. Ann N Y Acad Sci 1997;826–103-16 [DOI] [PubMed] [Google Scholar]
  • 40. Brown WR, Moody DM, Thore CR, et al. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J Neurol Sci 2007;257:62–66. Epub 2007 Feb 23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Moody DM, Thore CR, Anstrom JA, et al. Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis. Radiology 2004;223:883–90 [DOI] [PubMed] [Google Scholar]
  • 42. Conde JR, Streit WJ. Microglia in the aging brain. J Neuropathol Exp Neurol 2006;65:199–203 [DOI] [PubMed] [Google Scholar]
  • 43. Ball MJ. Leukoaraiosis explained. Lancet 1989;8638:612–13 [DOI] [PubMed] [Google Scholar]
  • 44. Mirsen TR, Lee DH, Wong CJ, et al. Clinical correlates of white matter changes on magnetic resonance imaging scans of the brain. Arch Neurol 1991;48:1015–21 [DOI] [PubMed] [Google Scholar]
  • 45. Davis PH, Dawson JD, Riley WA, et al. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine study. Circulation 2001;104:2815–19 [DOI] [PubMed] [Google Scholar]
  • 46. Simon A, Gariepy J, Chironi G, et al. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002;20:159–69 [DOI] [PubMed] [Google Scholar]
  • 47. Manolio TA, Burke GL, O'Leary DH, et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:356–65 [DOI] [PubMed] [Google Scholar]
  • 48. Tanaka T, Shimizu T, Fukuhara T. The relationship between leukoaraiosis volume and parameters of carotid artery duplex ultrasonographic scanning in asymptomatic diabetic patients. Comput Med Imaging Graph 2009;33:489–93 [DOI] [PubMed] [Google Scholar]
  • 49. Manolio TA, Kronmal RA, Burke GL, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke 1994;25:318–27 [DOI] [PubMed] [Google Scholar]
  • 50. Schmidt R, Petrovic K, Ropele S, et al. Progression of leukoaraiosis and cognition. Stroke 2007;38:2619–25 [DOI] [PubMed] [Google Scholar]
  • 51. Liao D, Cooper L, Cai J, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment and its control: the ARIC study—Atherosclerosis Risk in Communities Study. Stroke 1996;27:2262–70 [DOI] [PubMed] [Google Scholar]
  • 52. Schmidt R, Fazekas F, Offenbacher H, et al. Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol 1991;48:417–20 [DOI] [PubMed] [Google Scholar]
  • 53. Kertesz A, Black SE, Tokar G, et al. Periventricular and subcortical hyperintensities on magnetic resonance imaging: “rims, caps, and unidentified bright objects.” Arch Neurol 1988;45:404–08 [DOI] [PubMed] [Google Scholar]
  • 54. Awad IA, Spetzler RF, Hodak JA, et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with cerebrovascular risk factors. Stroke 1986;17:1084–89 [DOI] [PubMed] [Google Scholar]
  • 55. George AE, de Leon MJ, Gentes CI, et al. Leukoencephalopathy in normal and pathologic aging. I. CT of brain lucencies. AJNR Am J Neuroradiol 1986;7:561–66 [PMC free article] [PubMed] [Google Scholar]
  • 56. Murray AD, Staff RT, Shenkin SD, et al. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 2005;237:251–57 [DOI] [PubMed] [Google Scholar]
  • 57. Khan U, Porteous L, Hassan A, et al. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007;78:702–06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Ouhlous M, Flach Z, de Weert TT, et al. Carotid plaque composition and cerebral infarction: MR imaging study. AJNR Am J Neuroradiol 2005;26:1044–49 [PMC free article] [PubMed] [Google Scholar]
  • 59. Altaf N, Morgan PS, Moody A, et al. Brain white matter hyperintensities are associated with carotid intraplaque hemorrhage. Radiology 2008;248:202–09 [DOI] [PubMed] [Google Scholar]

Articles from AJNR: American Journal of Neuroradiology are provided here courtesy of American Society of Neuroradiology

RESOURCES